FBIO (Fortress Biotech) Net Margin %: 688.20% (As of Mar. 2026)


FBIO Fortress Biotech Inc FBIO
44 GF Score
Price $3.14
GF Value $1.23
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Fortress Biotech Net Margin %?

Fortress Biotech FBIO -1.26% 44 Net Margin % is 688.20% as of Mar. 2026. GuruFocus rates FBIO with a GF Score™ of 44/100 and a GF Value™ of $1.23 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 947 Biotechnology companies, Fortress Biotech ranks better than 98.63% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Fortress Biotech's Net Income for the three months ended in Mar. 2026 was $110.37 Mil. Fortress Biotech's Revenue for the three months ended in Mar. 2026 was $16.04 Mil. Therefore, Fortress Biotech's net margin for the quarter that ended in Mar. 2026 was 688.20%.

The historical rank and industry rank for Fortress Biotech's Net Margin % or its related term are showing as below:

FBIO' s Net Margin % Range Over the Past 10 Years
Min: -387.8   Med: -105.56   Max: 193.12
Current: 193.12

FBIO's Net Margin % is ranked better than
98.63% of 947 companies
in the Biotechnology industry
Industry Median: -89.56 vs FBIO: 193.12

Fortress Biotech  (NAS:FBIO) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Fortress Biotech Net Margin % Related Terms

Fortress Biotech Net Margin % Historical Data

* Premium members only.

The historical data trend for Fortress Biotech's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fortress Biotech Net Margin % Chart

Fortress Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -94.06 -114.30 -71.75 -79.75 10.77

Fortress Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -80.55 94.35 33.18 -24.49 688.20

FBIO vs PTHS, IBIO, NRXS: Net Margin % Comparison

For the Biotechnology subindustry, Fortress Biotech's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fortress Biotech Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fortress Biotech's Net Margin % distribution charts can be found below:

* The bar in red indicates where Fortress Biotech's Net Margin % falls into.


FBIO
44GF Score
Fortress Biotech Inc FBIO
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fortress Biotech Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Fortress Biotech's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=6.815/63.262
=10.77 %

Fortress Biotech's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=110.373/16.038
=688.20 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 688.20% mean?
Fortress Biotech (FBIO) has a Net Margin % of 688.20% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Fortress Biotech and its competitors. According to the industry distribution chart, Fortress Biotech ranks #13 out of 947 companies in the Biotechnology industry, placing it in the top 1.4%.
Is Fortress Biotech's Net Margin % too high?
Fortress Biotech's current Net Margin % is 688.20%. Based on the distribution chart, Fortress Biotech ranks #13 out of 947 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Fortress Biotech has a GF Score™ of 44/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fortress Biotech's Net Margin % compare to PTHS and IBIO?
According to the Biotechnology industry distribution chart, Fortress Biotech ranks #13 out of 947 companies for Net Margin %. This places Fortress Biotech in the top 1% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Fortress Biotech and its competitors. Fortress Biotech's current Net Margin % is 688.20%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fortress Biotech stock overvalued right now?
Based on GuruFocus' analysis, Fortress Biotech (FBIO) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.23, compared to a current price of $3.14 — trading 155.3% above its estimated fair value. The current Net Margin % is 688.20%. Fortress Biotech's overall GF Score™ is 44/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Fortress Biotech (FBIO), the current Net Margin % is 688.20% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fortress Biotech (FBIO) Overvalued in 2026?

Based on GuruFocus' analysis, Fortress Biotech stock appears to be overvalued. The current stock price of $3.14 is trading 155.3% above its estimated GF Value™ of $1.23. GuruFocus considers Fortress Biotech to be Significantly Overvalued.

Key valuation signals for FBIO:

  • Net Margin %: 688.20%
  • GF Value™: $1.23 vs. price of $3.14 (155.3% above fair value)
  • GF Score™: 44/100 with 7 warning signs

No single metric tells the full story. See the FBIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fortress Biotech Business Description

Address 1111 Kane Concourse, Suite 301, Bay Harbor Island, FL, USA, 33154
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.
44GF Score

Get the complete analysis for FBIO

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.14
Price
$1.23
GF Value